Model for Care - Focus on HBV, Introductory Lecture- Jordan Feld, MD, MPH

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Emergency Department Screening: Strategy for Elimination through an Innovative HBV and HCV Screening, Care, and Cure Program- S. Wang

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Rwanda’s Model for Care- Jean Damascene Makuza, MD

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Changes of the Composition of the Hepatitis B Virus (HBV) surface Antigen (HBsAg) are Associated with HBsAg Loss during Nucleos(tid)e Analogues and Peg-interferon-alfa2a Treatment- M. Pfefferkorn

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Model for Care - Focus on HCV, Introductory Lecture- Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Pakistan’s Model for Care- Huma Qureshi, MD

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Evaluation of the Hepatitis C Care Cascade in the Country of Georgia: Monitoring Progress towards Elimination- T. Tsertsvadze

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Strategies towards Elimination of Hepatitis C in Iceland: Models of Care for the Treatment as Prevention for Hepatitis C (TraP HeP C) Program- M. Gottfredsson

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Micro-Elimination of Hepatitis C amongst People Living with HIV (PLHIV) in Punjab, India- P. Katapur

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Integration of Hepatitis C Treatment Services with Harm Reduction Service Centers for People who Inject Drugs in Kenya: Experience from Test and Link to Care for Injecting Drug Users Study- M. Nyakowa

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Towards the Elimination of HCV in British Columbia: A strategy to Address the “messy middle”- B. Conway

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Real-World Challenges to and Opportunities for Microelimination in Two Remote Communities in Northwestern Ontario- D. Smookler

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Policy Implementation Index Based off of Patient Reported Outcomes: The Hep-CORE Study- A. Palayew

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Mongolia’s Model for Care- Naranjargal Dashdorj, MD, PhD

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Hepatitis C Elimination in the Netherlands (CELINE): a Nationwide Study Retrieving Lost to Follow-Up Chronic Hepatitis C Patients- M. Van Dijk

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Oral Prescription Opioid Use should be Considered a Risk Factor for HCV Infection: Another Step Toward HCV Elimination- B. Hack

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Stopping Nucleos(t)ide Analogues: Clinical outcomes of HBs Loss, retreatment and flares- Pietro Lampertico, MD, PhD

International Workshop on HBV Cure 2019

Immunological response after stopping Nucs- Andre Boonstra

International Workshop on HBV Cure 2019

Virological biomarkers in patients stopping Nucs- Florian van Bommel, MD

International Workshop on HBV Cure 2019

Review of the FDA/EMA HBV Endpoints Meeting- Fabien Zoulim, MD, PhD

International Workshop on HBV Cure 2019

Are ALT Flares Associated with Improved Virological Clearance- Harry Janssen, MD, PhD

International Workshop on HBV Cure 2019

High Resolution of Exhausted T cells Ex Vivo in Chronic HBV Infection- Robert Thimme

International Workshop on HBV Cure 2019

Restoration of B cell Antibody Production in Chronic HBV patients- Mala Maini, MD, PhD

International Workshop on HBV Cure 2019

Are HBcrAg, HBV RNA and anti-HBc Viable Biomarkers- Florian van Bommel, MD

International Workshop on HBV Cure 2019